Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
grade F 242.01 -0.63% -1.54
BDX closed down 0.63 percent on Friday, June 5, 2020, on 1.58 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Flat
Historical BDX trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Spinning Top Other -0.63%
Down 3 Days in a Row Weakness -0.42%
Narrow Range Bar Range Contraction -1.02%
NR7 Range Contraction -1.02%
Fell Below 50 DMA Bearish -1.16%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.16%
Crossed Above 50 DMA Bullish -1.99%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Medicine Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies Cancers Medical Technology Catheters Medical Tests Medical Devices Drug Delivery Treatment Of Diabetes Healthcare Associated Infections Healthcare Institutions Syringe Drug Delivery Systems Laboratory Products Clinical Tools Becton Becton Dickinson Franklin Lakes Reagent Systems

Is BDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 286.72
52 Week Low 197.75
Average Volume 2,207,583
200-Day Moving Average 253.73
50-Day Moving Average 248.95
20-Day Moving Average 249.05
10-Day Moving Average 241.36
Average True Range 7.45
ADX 16.98
+DI 22.98
-DI 28.27
Chandelier Exit (Long, 3 ATRs ) 246.07
Chandelier Exit (Short, 3 ATRs ) 249.75
Upper Bollinger Band 269.37
Lower Bollinger Band 228.73
Percent B (%b) 0.33
BandWidth 16.32
MACD Line -3.01
MACD Signal Line -2.37
MACD Histogram -0.6395
Fundamentals Value
Market Cap 55.07 Billion
Num Shares 228 Million
EPS 3.45
Price-to-Earnings (P/E) Ratio 70.15
Price-to-Sales 3.93
Price-to-Book 3.79
PEG Ratio 2.05
Dividend 2.92
Dividend Yield 1.21%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 247.35
Resistance 3 (R3) 247.55 245.98 246.46
Resistance 2 (R2) 245.98 244.62 245.88 246.16
Resistance 1 (R1) 243.99 243.78 243.21 243.79 245.87
Pivot Point 242.42 242.42 242.02 242.32 242.42
Support 1 (S1) 240.43 241.06 239.65 240.23 238.15
Support 2 (S2) 238.86 240.22 238.76 237.86
Support 3 (S3) 236.87 238.86 237.56
Support 4 (S4) 236.67